LCY Trend Radar
Cell-derived vesicles marketed for skin and hair regeneration, and a regulatory flashpoint.
Editorial draft, pending expert review.Grades here are provisional editorial calls and may change after review. This is not medical advice.
Qualitative editorial call based on media coverage and growing research output. Search and social signals have not been quantified.
Updated 24 September 2026 · Trend status is a qualitative editorial call. How we grade
Exosome serums and treatments promise regeneration. Early human studies are encouraging but small, and the US FDA says no exosome product is approved.
